Trial Profile
A randomized, controlled trial to evaluate the safety and efficacy of the ZoMaxx drug eluting coronary stent system as compared to the TAXUS Express2 paclitaxel-eluting stent in de novo coronary artery lesions.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Zotarolimus (Primary) ; Paclitaxel
- Indications Angina pectoris; Coronary artery disease; Coronary artery restenosis; Myocardial ischaemia
- Focus Therapeutic Use
- Acronyms ZOMAXX-II
- 17 May 2012 Results published in the International Journal of Cardiology.
- 09 Jan 2012 Actual end date (Jan 2012) added as reported by ClinicalTrials.gov.
- 09 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.